Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials

Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials

<h3>Aims</h3><p dir="ltr">The once‐weekly insulin icodec, a new basal insulin analog, may positively support a reduction in injection frequency and improve adherence to therapy in type 2 diabetes (T2D). This study aimed to evaluate the safety and efficacy of insulin icode...

Full description

Saved in:
Bibliographic Details
Main Author: Mushood Ahmed (19231379) (author)
Other Authors: Aimen Shafiq (21767660) (author), Hira Javaid (16729233) (author), Hritvik Jain (19757091) (author), Abdulqadir J. Nashwan (11659453) (author), Qura Tul‐Ain (21767663) (author), Jawad Basit (19231376) (author)
Published: 2024
Subjects:
Biomedical and clinical sciences
Medical biochemistry and metabolomics
Pharmacology and pharmaceutical sciences
insulin
insulin glargine
insulin icodec
type 2 diabetes
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items